Page 100 - Read Online

Page 8 of 10 Sell et al. Mini-invasive Surg 2024;8:3 https://dx.doi.org/10.20517/2574-1225.2023.105

incidence and survival. Laryngoscope 2015;125:2491-7. DOI PubMed
10. Porceddu S, Martin J, Shanker G, et al. Paranasal sinus tumors: Peter MacCallum Cancer Institute experience. Head Neck
2004;26:322-30. DOI PubMed
11. Suárez C, Ferlito A, Lund VJ, et al. Management of the orbit in malignant sinonasal tumors. Head Neck 2008;30:242-50. DOI
PubMed
12. Pfister DG, Spencer S, Adelstein D, et al. Head and neck cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J
Natl Compr Canc Netw 2020;18:873-98. DOI PubMed
13. Workman AD, Palmer JN, Adappa ND. Posttreatment surveillance for sinonasal malignancy. Curr Opin Otolaryngol Head Neck Surg
2017;25:86-92. DOI PubMed
14. Nyquist GG, Patel PN, Vimawala S, et al. Surgery with post-operative endoscopy improves recurrence detection in sinonasal
malignancies. Ann Otol Rhinol Laryngol 2022;131:140-6. DOI PubMed
15. Khalili S, Worrall DM, Brooks S, et al. Endoscopy versus imaging: analysis of surveillance methods in sinonasal malignancy. Head
Neck 2016;38:1229-33. DOI PubMed
16. Zocchi J, Pietrobon G, Campomagnani I, et al. The role of a post therapeutic surveillance program for sinonasal malignancies: analysis
of 417 patients. Head Neck 2020;42:963-73. DOI PubMed
18
17. Schwartz JS, Brooks SG, Stubbs V, et al. Temporal patterns of F-fluorodeoxyglucose positron emission tomography/computed
tomography sinonasal uptake after treatment of sinonasal malignancy. Int Forum Allergy Rhinol 2016;6:1301-7. DOI PubMed
18. Chao SS, Loh KS, Tan LKS. Modalities of surveillance in treated nasopharyngeal cancer. Otolaryngol Head Neck Surg 2003;129:61-4.
DOI PubMed
19. Thawani R, Kim MS, Arastu A, et al. The contemporary management of cancers of the sinonasal tract in adults. CA Cancer J Clin
2023;73:72-112. DOI PubMed PMC
20. Guevara-Canales JO, Gutiérrez-Morales MM, Sacsaquispe-Contreras SJS, Sánchez-Lihón J, Morales-Vadillo R. Malignant melanoma
of the oral cavity. Review of the literature and experience in a Peruvian Population. Med Oral Patol Oral Cir Bucal 2012;17:e206-11.
DOI PubMed PMC
21. Maroldi R, Ravanelli M, Farina D, et al. Post-treatment evaluation of paranasal sinuses after treatment of sinonasal neoplasms.
Neuroimaging Clin N Am 2015;25:667-85. DOI PubMed
22. Kubota K, Yokoyama J, Yamaguchi K, et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after
radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging 2004;31:590-5. DOI
23. Lund VJ, Stammberger H, Nicolai P, et al. European position paper on endoscopic management of tumours of the nose, paranasal
sinuses and skull base. Rhinol Suppl 2010;22:1-143. PubMed
24. Loevner LA, Sonners AI. Imaging of neoplasms of the paranasal sinuses. Magn Reson Imaging Clin N Am 2002;10:467-93. DOI
PubMed
25. Ng SH, Liu HM, Ko SF, Hao SP, Chong VFH. Posttreatment imaging of the nasopharynx. Eur J Radiol 2002;44:82-95. DOI PubMed
26. Ahmad S, Le CH, Chiu AG, Chang EH. Incidence of intracranial radiation necrosis following postoperative radiation therapy for
sinonasal malignancies. Laryngoscope 2016;126:2445-50. DOI PubMed
27. Oysu AS, Ayanoglu E, Kodalli N, Oysu C, Uneri C, Erzen C. Dynamic contrast-enhanced MRI in the differentiation of posttreatment
fibrosis from recurrent carcinoma of the head and neck. Clin Imaging 2005;29:307-12. DOI PubMed
28. Tangyoosuk T, Lertbutsayanukul C, Jittapiromsak N. Utility of diffusion-weighted magnetic resonance imaging in predicting the
treatment response of nasopharyngeal carcinoma. Neuroradiol J 2022;35:477-85. DOI PubMed PMC
29. Galbán CJ, Mukherji SK, Chenevert TL, et al. A feasibility study of parametric response map analysis of diffusion-weighted magnetic
resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol
2009;2:184-90. DOI PubMed PMC
30. Vandecaveye V, Dirix P, De Keyzer F, et al. Predictive value of diffusion-weighted magnetic resonance imaging during
chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 2010;20:1703-14. DOI PubMed
31. Kawaguchi M, Kato H, Tomita H, et al. Imaging characteristics of malignant sinonasal tumors. J Clin Med 2017;6:116. DOI PubMed
PMC
32. Bair RJ, Chick JF, Chauhan NR, French C, Madan R. Demystifying NUT midline carcinoma: radiologic and pathologic correlations of
an aggressive malignancy. AJR Am J Roentgenol 2014;203:W391-9. DOI PubMed
33. Berrington de González A, Mahesh M, Kim KP, et al. Projected cancer risks from computed tomographic scans performed in the
United States in 2007. Arch Intern Med 2009;169:2071-7. DOI PubMed PMC
34. Brenner DJ, Hall EJ. Computed tomography - an increasing source of radiation exposure. N Engl J Med 2007;357:2277-84. DOI
PubMed
35. Lee JC, Kim JS, Lee JH, et al. F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell
carcinoma. Oral Oncol 2007;43:686-92. DOI
36. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of
2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135-41. DOI PubMed
37. Villar R, Ramos B, Acosta M, Haro JJ, Gómez A. Recurrent adenocarcinoma of the sinonasal tract. Oral Maxillofac Surg
2013;17:155-8. DOI PubMed
38. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: